UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation

Lakshmikanth, T; Heuts, F; Muvva, SJ; Wallin, RP; Persson, AK; Fauriat, C; Applequist, SE; ... Juarez, JG; + view all (2016) In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation. European Journal of Immunology , 46 (7) pp. 1758-1769. 10.1002/eji.201545991. Green open access

[thumbnail of Lakshmikanth_et_al-2016 In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation VOR.pdf]
Preview
Text
Lakshmikanth_et_al-2016 In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation VOR.pdf

Download (3MB) | Preview

Abstract

The immunological attributes of stem cell grafts play an important role in the outcome of allogeneic stem cell transplants. Currently, ex vivo manipulation techniques such as bulk T cell depletion or positive selection of CD34(+) cells are utilized to improve the immunological attributes of grafts and minimize the potential for graft-versus-host disease (GvHD). Here, we demonstrate a novel graft engineering technique, which utilizes the immunomodulatory drug FTY720 for in vivo depletion of naïve T (TN ) cells from donor G-CSF-mobilized grafts without ex vivo manipulation. We show that treatment of donor mice with FTY720 during mobilization depletes grafts of TN cells and prevents lethal GvHD following transplantation in a major mismatch setting. Importantly, both stem cells and NK cells are retained in the FTY720-treated grafts. FTY720 treatment does not negatively affect the engraftment potential of stem cells as demonstrated in our congenic transplants or the functionality of NK cells. In addition, potentially useful memory T cells may be retained in the graft. These findings suggest that FTY720 may be used to optimize the immunological attributes of G-CSF-mobilized grafts by removing potentially deleterious TN cells which can contribute to GvHD, and by retaining useful cells which can promote immunity in the recipient.

Type: Article
Title: In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/eji.201545991
Publisher version: http://dx.doi.org/10.1002/eji.201545991
Language: English
Additional information: Copyright © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Keywords: Allogeneic stem cell transplantation, Graft engineering, Graft-versus-host disease, Stem cell mobilization, T cells
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/1489840
Downloads since deposit
83Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item